Literature DB >> 23643329

International challenges of self-sufficiency in blood products.

N Dhingra1.   

Abstract

To face known and emerging threats to public health, all countries have to overcome the challenges of providing sufficient supplies of blood and blood products of the highest quality and safety. Unfortunately, self-sufficiency is not yet a reality in many countries. In 2011, experts from WHO addressed the urgent need to establish strategies and mechanisms for achieving this goal. A summary of these recommendations is further discussed.
Copyright © 2013 N. Dhingra. Published by Elsevier SAS.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643329     DOI: 10.1016/j.tracli.2013.03.003

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  4 in total

1.  Blood Products and the Commodification Debate: The Blurry Concept of Altruism and the 'Implicit Price' of Readily Available Body Parts.

Authors:  Annette Dufner
Journal:  HEC Forum       Date:  2015-12

2.  Prophylactic plasma transfusion for patients undergoing non-cardiac surgery.

Authors:  Jonathan Huber; Simon J Stanworth; Carolyn Doree; Marialena Trivella; Susan J Brunskill; Sally Hopewell; Kirstin L Wilkinson; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

3.  Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.

Authors:  Jonathan Huber; Simon J Stanworth; Carolyn Doree; Patricia M Fortin; Marialena Trivella; Susan J Brunskill; Sally Hopewell; Kirstin L Wilkinson; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2019-11-28

4.  Using Digital Platforms to Promote Blood Donation: Motivational and Preliminary Evidence from Latin America and Spain.

Authors:  Joan Torrent-Sellens; Cristian Salazar-Concha; Pilar Ficapal-Cusí; Francesc Saigí-Rubió
Journal:  Int J Environ Res Public Health       Date:  2021-04-17       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.